Terms: = Lung cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
9186 results:
1. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
2. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
[TBL] [Abstract] [Full Text] [Related]
3. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
4. treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
[TBL] [Abstract] [Full Text] [Related]
5. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central lung Tumor.
Rim CH; Yoon WS; Park S
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674184
[No Abstract] [Full Text] [Related]
6. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract] [Full Text] [Related]
7. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/TNFRSF17 axis.
He M; Jiang W; Li X; Liu H; Ren H; Lin Y
BMC Cancer; 2024 Apr; 24(1):505. PubMed ID: 38649856
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation.
Gao E; Wang Y; Fan GL; Xu G; Wu ZY; Liu ZJ; Liu JC; Mao LF; Hou X; Li S
Sci Rep; 2024 Apr; 14(1):9223. PubMed ID: 38649732
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
[TBL] [Abstract] [Full Text] [Related]
10. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
11. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
12. Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses.
Xu K; Lu W; Yu A; Wu H; He J
BMC Cancer; 2024 Apr; 24(1):491. PubMed ID: 38632512
[TBL] [Abstract] [Full Text] [Related]
13. Uncertainty among patients with advanced-stage lung cancer.
Wongkalasin K; Matchim Y; Kanhasing R; Pimvichai S
Int J Palliat Nurs; 2024 Apr; 30(4):160-169. PubMed ID: 38630643
[TBL] [Abstract] [Full Text] [Related]
14. Extrapleural pneumonectomy for sarcoma: Outcomes of adult patients at a specialized center.
Zhang BY; Wilson-Smith AR; Connolly EA; Strach MC; Ussher N; Yan T; Bhadri VA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2065. PubMed ID: 38627902
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
[TBL] [Abstract] [Full Text] [Related]
16. Current practices of craniospinal irradiation techniques in Turkey: a comprehensive dosimetric analysis.
Şenkesen Ö; Tezcanlı E; Alkaya F; İspir B; Çatlı S; Yeşil A; Bezirganoglu E; Turan S; Köksal C; Güray G; Hacıislamoğlu E; Durmuş İF; Çavdar Ş; Aksu T; Çolak N; Küçükmorkoç E; Doğan M; Ercan T; Karaköse F; Alpan V; Ceylan C; Poyraz G; Nalbant N; Kınay Ş; İpek S; Kayalılar N; Tatlı H; Zhu M
Radiat Oncol; 2024 Apr; 19(1):49. PubMed ID: 38627747
[TBL] [Abstract] [Full Text] [Related]
17. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
Li H; Huntington S; Gross C; Wang SY
PLoS One; 2024; 19(4):e0300789. PubMed ID: 38625861
[TBL] [Abstract] [Full Text] [Related]
18. Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.
Xu Y; Zhang Q; Chen Z; Yang S; Chen H; Xiao X; Jiang H
BMC Pulm Med; 2024 Apr; 24(1):174. PubMed ID: 38609918
[TBL] [Abstract] [Full Text] [Related]
19. Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Park SJ; Ju S; Goh SH; Yoon BH; Park JL; Kim JH; Lee S; Lee SJ; Kwon Y; Lee W; Park KC; Lee GK; Park SY; Kim S; Kim SY; Han JY; Lee C
Cancer Res; 2024 May; 84(9):1491-1503. PubMed ID: 38607364
[TBL] [Abstract] [Full Text] [Related]
20. Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
John N; Schlintl V; Sassmann T; Lindenmann J; Fediuk M; Wurm R; Douschan P; Zacharias M; Kalson L; Posch F; Absenger G; Brcic L; Jost PJ; Terbuch A
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604811
[TBL] [Abstract] [Full Text] [Related]
[Next]
